European journal of cancer care
-
Eur J Cancer Care (Engl) · Sep 2019
Running on empathy: Relationship of empathy to compassion satisfaction and compassion fatigue in cancer healthcare professionals.
The aim of this study is to examine the relationship of empathy and professional quality of life in cancer healthcare professionals. ⋯ These findings suggest that healthcare professionals working in cancer care are at risk of compassion fatigue. Also, healthcare professionals working in cancer care experience personal distress that may impact negatively on professional quality of life. Implications for practice include a need to identify those HCPs who are at risk of compassion fatigue. The implication for further research suggests further exploration of the impact of personal distress felt by cancer healthcare professionals during empathic engagement.
-
Eur J Cancer Care (Engl) · Dec 1998
ReviewResearch with families in palliative care: conceptual and methodological challenges.
Conducting research with families of individuals receiving palliative care is challenging. Issues contributing to the challenge include defining the family, determining the unit of analysis in the level of inquiry, and identifying pathways to knowledge about the family. The purpose of this paper is to provide an overview of the major conceptual and methodological issues facing family researchers in general, with an aim to examining how these issues impact researchers studying families of individuals receiving palliative care.
-
Eur J Cancer Care (Engl) · May 2010
ReviewBest supportive care in lung cancer trials is inadequately described: a systematic review.
The objective of the paper was to identify and discuss clinical terms associated with the availability and delivery of best supportive care for patients with lung cancer in randomised controlled clinical trials. Systematic review was carried out of relevant studies without language restrictions identified through Medline, EMBASE, Science Citation Index (Web of Science and ISI Proceedings) and Cochrane Library. Reference lists of retrieved articles were also searched to identify further studies. ⋯ None of the identified studies provided a clear definition of a patient pathway in relation to best supportive care, or a clear list of components. Clinical studies are being conducted without a clear definition of the best supportive care provided in the comparator arms of trials. Inadequate definitions mean that all direct and indirect comparisons in trials comparing active treatments with best supportive care must be interpreted with caution.
-
Eur J Cancer Care (Engl) · Jan 2009
Randomized Controlled Trial Multicenter StudyLong-term glutamate supplementation failed to protect against peripheral neurotoxicity of paclitaxel.
Toxic peripheral neuropathy is still a significant limiting factor for chemotherapy with paclitaxel (PAC), although glutamate and its closely related amino acid glutamine were claimed to ameliorate PAC neurotoxicity. This pilot trial aimed to evaluate the role of glutamate supplementation for preventing PAC-induced peripheral neuropathy in a randomized, placebo-controlled, double-blinded clinical and electro-diagnostic study. Forty-three ovarian cancer patients were available for analysis following six cycles of the same PAC-containing regimen: 23 had been supplemented by glutamate all along the treatment period, at a daily dose of three times 500 mg (group G), and 20 had received a placebo (group P). ⋯ However, this difference reached statistical significance only with regard to reported pain sensation (P = 0.011). Also the frequency of abnormal electro-diagnostic findings showed similarity between the two groups (G: 7/23 = 30.4%; P: 6/20 = 30%). This pilot study leads to the conclusion that glutamate supplementation at the chosen regimen fails to protect against peripheral neurotoxicity of PAC.
-
Eur J Cancer Care (Engl) · Jul 2017
Retracted: Symptom trajectories and occurrence in older Saudi children with cancer during a course of chemotherapy.
This research aimed to describe changes in symptom occurrence and severity of the 31 symptoms during the chemotherapy cycle at three time points. This descriptive, longitudinal study investigated Saudi children who underwent a cycle of chemotherapy (n = 132) in four tertiary hospitals. The Arabic version of the Memorial Symptom Assessment Scale, Karnofsky Performance Status and a demographic questionnaire were used. ⋯ This study is the first to examine the trajectory of multiple symptoms that children experience during a cycle of chemotherapy in Saudi Arabia. Children in this study reported a high number of symptoms across the entire cycle of chemotherapy. Intervention studies are needed to improve care for these symptoms.